FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Rabeprazole Sodium Delayed-Release Tablets
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories: Anesthesia; Neurology; Pediatric

American Regent/Luitpold (Reverified 06/09/2020)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.4 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-0401-25) Limited Availability American Regent is currently releasing the 0.4mg/mL, 1 mL vial, NDC 00517-0401-25 Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English